tiprankstipranks
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market

Medicenna Therapeutics Corp (MDNAF) Income Statement

Compare
218 Followers

Medicenna Therapeutics Corp Income Statement

Last quarter (Q3 2024), Medicenna Therapeutics Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Medicenna Therapeutics Corp's net income was C$-5.19M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -5.00KC$ -5.00KC$ -38.00KC$ -40.00K-
Operating Expenses
C$ 19.66MC$ 16.30MC$ 22.47MC$ 17.39MC$ 8.24M
Depreciation and Amortization
C$ 5.00KC$ 5.00KC$ 38.00KC$ 40.00K-
EBITDA
C$ -18.67MC$ -16.30MC$ -22.54MC$ -17.25MC$ -8.27M
Operating Income
C$ -19.66MC$ -21.64MC$ -22.30MC$ -17.19MC$ -8.21M
Other Income/Expenses
C$ -5.80MC$ 7.00MC$ 1.65MC$ 106.00KC$ 919.00K
Pretax Income
C$ -25.47MC$ -10.05MC$ -22.58MC$ -17.29MC$ -8.28M
Net Income
C$ -25.47MC$ 1.55MC$ -22.65MC$ -17.18MC$ -8.31M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.37C$ 0.02C$ -0.42C$ -0.35C$ -0.26
Diluted EPS
C$ -0.37C$ 0.02C$ -0.42C$ -0.35C$ -0.26
Weighted Average Shares Outstanding
69.64M 64.74M 54.29M 49.66M 31.90M
Weighted Average Shares Outstanding (Diluted)
69.64M 64.74M 54.29M 49.66M 31.90M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis